Johnson & Johnson Sunscreen
The Johnson & Johnson Sunscreen litigation was centralized before Judge Raag Singhal in the Southern District of Florida in October 2021, consolidating claims arising from a 2021 recall of certain aerosol sunscreen products after internal testing detected trace benzene contamination in some lots. The consolidated claims combined an economic-loss theory (purchasers seeking the value of a recalled, unusable product) with a personal-injury theory alleging that benzene exposure through sunscreen use contributed to skin cancer or other health effects.
With zero actions currently pending against sixteen total actions ever filed, this docket sits at the far end of the resolution spectrum: essentially the entire filed population has closed out, whether through dismissal, individual resolution, or another disposition not reflected in the pending-action count alone. That trajectory is notably different from other benzene-contamination or consumer-product recall MDLs that have grown into large, multi-thousand-action dockets, and the divergence is itself informative — it suggests the underlying causation theory, injury population, or claim volume in this instance did not develop the momentum that drives a mass tort docket to scale.
For anyone studying how recall-driven products-liability MDLs can diverge sharply in outcome even when they share a superficially similar fact pattern — a consumer-product recall tied to a contaminant of concern — this docket is a useful data point precisely because of how quickly and completely it wound down. Criterica Intelligence's platform tracks this kind of full-lifecycle read, including dockets that resolve to zero, across every active and recently active MDL, because understanding why a docket did not scale is as useful a structural signal as understanding why one did. A companion capital brief covering this docket's procedural history is available through Criterica Capital.
Claims arising from a 2021 recall of certain Johnson & Johnson aerosol sunscreen products after internal testing found trace benzene contamination in some lots, combining economic-loss claims from purchasers with personal-injury claims alleging health effects from use.
The entire population of actions ever filed in this MDL — sixteen total — has closed out as of the JPML's September 2026 report, through dismissal, individual resolution, or another disposition not broken out in the pending-action count.
Not necessarily — a pending-action count reflects docket status, not a merits determination. It does indicate that whatever claim population existed here did not develop into an ongoing, actively litigated mass tort.
The sharp contrast between this docket's rapid wind-down and the sustained scale of other contamination-driven mass torts illustrates that a superficially similar recall fact pattern does not guarantee a similar claims trajectory — a distinction Criterica Intelligence tracks across comparable dockets.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.